Anionic Microparticles are a Potent Delivery System for Recombinant Antigens from Neisseria meningitidis Serotype B

Journal of Pharmaceutical Sciences

Volumn 93, Issue 2, 2004, Pages 273-282

  Singh, Manmohan ^a   Kazzaz, Jina ^a   Chesko, James ^a   Soenawan, Elawati ^a   Ugozzoli, Mildred ^a   Giuliani, Marzia ^b   Pizza, Mariagrazia ^b   Rappouli, Rino ^b   O'Hagan, Derek T ^a  

^a NOVARTIS PHARMA AG   (Switzerland)

^b CHIRON VACCINES   (Italy)

Author keywords

Microparticles; Neisseria meningitides type B (Men B) vaccine; Polylactide co glycolide polymer; Vaccine adjuvants; Vaccine delivery

Indexed keywords

ALUMINUM POTASSIUM SULFATE; ANIONIC SURFACTANT; DOCUSATE SODIUM; IMMUNOLOGICAL ADJUVANT; MENINGOCOCCUS VACCINE; NEISSERIA MENINGITIDIS TYPE B VACCINE; POLYGLACTIN; RECOMBINANT ANTIGEN; UNCLASSIFIED DRUG;

ADSORPTION; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY RESPONSE; ANTIGEN BINDING; ARTICLE; CONTROLLED STUDY; CPG ISLAND; DRUG DELIVERY SYSTEM; DRUG EFFICACY; DRUG FORMULATION; DRUG RELEASE; ELECTRICITY; ENZYME LINKED IMMUNOSORBENT ASSAY; EVAPORATION; HYDROPHOBICITY; IMMUNIZATION; IMMUNOGENICITY; IN VITRO STUDY; MOUSE; NEISSERIA MENINGITIDIS; NONHUMAN; SERUM BACTERICIDAL ACTIVITY; SOLVENT EFFECT;

EID: 0842289361     PISSN: 00223549     EISSN: None     Source Type: Journal    
DOI: 10.1002/jps.10538     Document Type: Article

References (29)

1. Gupta RK, Rost BE, Relyveld E, Siber GR. 1995. Adjuvant properties of aluminum and calcium compounds. In: Powell MF, Newman MJ, editors. Vaccine design: The subunit and adjuvant approach. New York: Plenum Press. pp 229-248.
2. Gupta RK, Siber GR. 1995. Adjuvants for human vaccines-Current status, problems and future prospects. Vaccine 13:1263-1276.
3. Singh M, O'Hagan DT. 1999. Recent advances in vaccine adjuvants. Nat Biotechnol 17:1075-1081.
4. Putney SD, Burke PA. 1998. Improving protein therapeutics with sustained-release formulations Nat Biotechnol 16:153-157.
5. Okada H, Toguchi H. 1995. Biodegradable microspheres in drug delivery. Crit Rev Ther Drug Car Syst 12:1-99.
6. O'Hagan DT, Rahman D, McGee JP, Jeffery H, Davies MC, Williams P, Davis SS, Challacombe SJ. 1991. Biodegradable microparticles as controlled release antigen delivery systems. Immunology 73:239-242.
7. Shahin R, Leef M, Eldridge J, Hudson M, Gilley R. 1995. Adjuvanticity and protective immunity elicited by Bordetella pertussis antigens encapsulated in poly(DL-lactide-co-glycolide) microspheres. Infect Immun 63:1195-1200.
8. Marx PA, Compans RW, Gettie A, Staas JK, Gilley RM, Mulligan MJ, Yamschikov GV, Chen D, Eldridge JH. 1993. Protection against vaginal SIV transmission with microencapsulated vaccine. Science 260:1323-1327.
9. Tseng JL, Komisar JL, Trout RN, Hunt RE, Chen JY, Johnson AJ, Pitt L, Ruble DL. 1995. Humoral immunity to aerosolized staphylococcal enterotoxin B (SEB), a superantigen, in monkeys vaccinated with SEB toxoid-containing microspheres. Infect Immun 63:2880-2885.
10. O'Hagan D, Singh M. 2003. Microparticles as vaccine adjuvants and delivery systems. Expert Rev Vaccines 2:269-283.
11. O'Hagan DT. 1997. The prospects for the development of new and improved vaccines through the use of microencapsulation technology. In: Levine MM, Woodrow GC, Kaper JB, Cobon GS, editors. New generation vaccines, Second Edition. New York: Marcel Dekker. Chapter 17, pp 215-228.
12. Johnson RE, Lanaski LA, Gupta V, Griffin MJ, Gaud HT, Needham TE, Zia H. 1991. Stability of atriopeptin III in poly (lactide-co-glycolide) microparticles. J Controlled Release 17:61.
13. Park TG, Lu W, Crotts G. 1995. Importance of in vitro experimental conditions on protein release kinetics, stability and polymer degradation in protein encapsulated poly (D,L-lactic acid-co-glycolic acid) microspheres. J Controlled Release 33:211.
14. Shenderova A, Burke TG, Schwendeman SP. 1999. The acidic microclimate in poly(lactide-co-glycolide) microspheres stabilizes camptothecins. Pharm Res 16:241-248.
15. Van de Weert M, Hennink WE, Jiskoot W. 2000. Protein instability in poly(lactic-co-glycolic) microparticles. Pharm Res 17:1159-1167.
16. Kazzaz J, Neidleman J, Singh M, Ott G, O'Hagan DT. 2000. Novel anionic microparticles are a potent adjuvant for the induction of cytotoxic T lymphocytes against recombinant p55 gag from HIV-1. J Controlled Release 67:347-356.
17. Otten G, Schaefer M, Greer C, Kazzaz J, Calderon-Cacia M, Ugozzoli M, Selby M, Singh M, Megede J, Barnet S, O'Hagan D, Donnelly J, Ulmer J. 2003. Introduction of broad and potent anti-HIV immune responses in rhesus macaques by priming with a DNA vaccine and boosting with protein-adsorbed PLG microparticles. J Virol 77:6087-6092.
18. Singh M, Briones M, Ugozzoli M, Kazzaz J, Klakamp S, Ott G, Donnelly J, O'Hagan DT. 2001. Cationic microparticles are effective delivery systems for immune stimulatory CpG DNA. Pharm Res 18:1476-1479.
19. Inactive Ingredient database. 2003. Center for Drug Evaluation and Research, U.S.F.D.A
20. Davis HL, Weeranta R, Waldschmidt TJ, Tygrett L, Schorr J, Krieg AM. 1998. CpG DNA is a potent enhancer of specific immunity in mice immunized with recombinant hepatitis B surface antigen. J Immunol 160:870-876.
21. Wildes SS, Tunkel AR. 2002. Meningococcal vaccines: A progress report. Bio Drugs 16:321-329.
22. Poolman JT. 1995. Development of a meningococcal vaccine. Infect Agents Dis 4:13-28.
23. Wall RA. 2002. Meningococcal disease: Treatment and prevention. Ann Med 34:624-634.
24. Pizza M, Scarlato V, Masignani V, Guiliani M, Grandi G, Rappuoli R et al. 2000. Identification of vaccine candidates against serogroup B Meningococcus by whole-genome sequencing. Science 287:1816-1820.
25. Comanducci M, Bambini S, Brunelli B, Adu-Bobie J, Arico B, Capecchi B, Guiliani M, Masignani V, Santini L, Savino S, Granoff D, Caugant D, Pizza M, Rappuoli R, Mora M. 2002. NadA, a novel vaccine candidate of Neisseria meningitides. J Exp Med 195:1445-1454.
26. Al-Shakhshir RH, Regnier FE, White JL, Hem SL. 1995. Contribution of electrostatic and hydrophobic interactions to the adsorption of protein by aluminium containing adjuvants. Vaccine 13:41-44.
27. Seeber SJ, White JL, Hem SJ. 1991. Predicting the adsorption of proteins by aluminium-containing adjuvants. Vaccine 9:201-203.
28. Singh M, Briones M, Ott G, O'Hagan D. 2000. Cationic microparticles: A potent delivery system for DNA vaccines. Proc Natl Acad Sci USA 97:811-816.
29. Briones M, Singh M, Ugozzoli M, Kazzaz J, Klakamp S, Ott G, O'Hagan D. 2001. The preparation, characterization, and evaluation of cationic microparticles for DNA vaccine delivery. Pharm Res 18:709-711.